HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Cryptococcosis — Clinical Guidelines

Overview

Cryptococcosis is a severe, opportunistic fungal infection primarily affecting immunocompromised individuals, including transplant recipients and those with HIV. It can manifest as meningitis, pulmonary disease, or disseminated infection with multi-organ involvement 1 2.

Diagnosis

Clinical Presentation: Non-specific symptoms like fever, headache, and respiratory issues; may include neurological signs in meningitis 1 2.

Laboratory Tests: Cryptococcal antigen (CrAg) testing in serum and cerebrospinal fluid (CSF) is highly sensitive and specific 6 7.

Imaging: Chest CT and other imaging modalities can reveal characteristic pulmonary lesions 3.

Biopsy and Cultures: Histopathological examination and fungal cultures from affected tissues or fluids are definitive 3 10.

Rapid Diagnostic Techniques: ROSE combined with CT-guided biopsies or EBUS-TBLB can expedite diagnosis 3.

Management

First-Line Treatment: Amphotericin B or echinocandins for severe cases, often combined with flucytosine 2 7.

Long-Term Therapy: Fluconazole for maintenance therapy following initial treatment 2 7.

Adjunctive Therapies: Immunoliposomes for targeted drug delivery to reduce toxicity 11.

Monitoring: Regular CrAg testing to monitor response and prevent relapse 6 7.

Special Populations

Immunocompromised Patients: Higher risk of disseminated disease and multi-organ failure; requires vigilant monitoring 1 7.

Hematology/Oncology Patients: Increased incidence of rare yeast infections; consider cryptococcosis in granulomatous changes 7.

Elderly and Comorbidities: Presence of comorbidities like diabetes can complicate diagnosis and management 10.

Key Recommendations

Use Cryptococcal Antigen Testing for early diagnosis in immunocompromised patients, including those without HIV 6 7 (Evidence: Strong).

Initiate with Amphotericin B or Echinocandins for severe cryptococcosis, followed by fluconazole for consolidation therapy 2 7 (Evidence: Strong).

Monitor CrAg Levels Regularly to assess treatment efficacy and prevent relapse 6 7 (Evidence: Moderate).

Consider Immunoliposome-Encapsulated Amphotericin B to reduce toxicity in severe cases 11 (Evidence: Weak).

Evaluate for Cryptococcosis in Granulomatous Lesions in hematology/oncology patients 7 (Evidence: Moderate).

References

1 Sanchez-Lobo D, Espinosa-Zerecero P, Cebrian-Garcia R, Garcia-Nava M, Cano-Garcia F, Garcia-Blanco MD et al.. Severe Disseminated Cryptococcosis Leading to Multi-organ Failure in a Renal Transplant Patient: A Case Report. Current medical imaging 2025. link 2 Chang CC, Harrison TS, Bicanic TA, Chayakulkeeree M, Sorrell TC, Warris A et al.. Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM. The Lancet. Infectious diseases 2024. link00731-4) 3 Cao J, Zhou R, He Q, Zhang M, Feng C. Value of rapid on-site evaluation combined with interventional pulmonology techniques in the diagnosis of pulmonary cryptococcosis. The clinical respiratory journal 2024. link 4 Sami MRS, Rani NA, Elahi MME, Hossain MS, Al Mueid MA, Rahim Z et al.. An immunoinformatics and extensive molecular dynamics study to develop a polyvalent multi-epitope vaccine against cryptococcosis. PloS one 2024. link 5 Zhu F, Zhou Z, Ma S, Xu Y, Tan C, Yang H et al.. Design of a cryptococcus neoformans vaccine by subtractive proteomics combined with immunoinformatics. International immunopharmacology 2024. link 6 Macrae C, Ellis J, Keddie SH, Falconer J, Bradley J, Keogh R et al.. Diagnostic performance of the IMMY cryptococcal antigen lateral flow assay on serum and cerebrospinal fluid for diagnosis of cryptococcosis in HIV-negative patients: a systematic review. BMC infectious diseases 2023. link 7 Chang CC, Hall V, Cooper C, Grigoriadis G, Beardsley J, Sorrell TC et al.. Consensus guidelines for the diagnosis and management of cryptococcosis and rare yeast infections in the haematology/oncology setting, 2021. Internal medicine journal 2021. link 8 Arechavala A, Negroni R, Messina F, Romero M, Marín E, Depardo R et al.. Cryptococcosis in an Infectious Diseases Hospital of Buenos Aires, Argentina. Revision of 2041 cases: Diagnosis, clinical features and therapeutics. Revista iberoamericana de micologia 2018. link 9 Lingegowda BP, Koh TH, Ong HS, Tan TT. Primary cutaneous cryptococcosis due to Cryptococcus gattii in Singapore. Singapore medical journal 2011. link 10 Chantranuwat C, Sittipunt C. Bronchiolitis obliterans organizing pneumonia caused by capsule-deficient cryptococcosis. The Southeast Asian journal of tropical medicine and public health 2005. link 11 Dromer F, Barbet J, Bolard J, Charreire J, Yeni P. Improvement of amphotericin B activity during experimental cryptococcosis by incorporation into specific immunoliposomes. Antimicrobial agents and chemotherapy 1990. link 12 Korvick J, Yu VL. Cryptococcal tonsillitis in a patient with chronic lymphocytic leukemia: an unusual manifestation of cryptococcal disease. American journal of hematology 1987. link 13 Ikeda R, Nishikawa A, Shinoda T, Fukazawa Y. Chemical characterization of capsular polysaccharide from Cryptococcus neoformans serotype A-D. Microbiology and immunology 1985. link 14 Henson DJ, Hill AR. Cryptococcal pneumonia: a fulminant presentation. The American journal of the medical sciences 1984. link 15 Braman RT. Cryptococcosis (torulosis) of prostate. Urology 1981. link90056-x) 16 Roberts SH, Gault MH, Fardy PW. Occurrence of two cases of cryptococcosis within 3 months on the same general medical ward. Canadian Medical Association journal 1976. link

Cryptococcosis